Skip to main content
# Title Department Research Year
61 Prodrugs of non-steroidal anti-inflammatory drugs (NSAIDs) and Amino acid esters as novel non-cyclooxygenase inhibitors for colorectal cancer chemoprevention 2022
62 New 1,2,4-oxadiazole/pyrrolidine hybrids as Topoisomerase IV and DNA gyrase inhibitors with promising antibacterial activity 2022
63 Silver Nanoparticles Stabilized by Poly (Vinyl Pyrrolidone) with Potential Anticancer Activity towards Prostate Cancer Department of Industrial Pharmacy 2022
64 Fluorometric and electrochemical dual-mode detection of toxic flavonoid rutin based on new nitrogen and sulfur co-doped carbon dots: Enhanced selectivity based on masking the interfering flavonoids with BSA complexation Department of Pharmaceutical Analytical Chemistry 2022
65 BOTANICAL STUDY AND FATTY ACIDS CHARACTERIZATION OF THE LEAVES OF DYPSIS PEMBANA (HE MOORE) BEENTJE &J. DRANSF. FAMILY ARECACEAE CULTIVATED IN EGYPT Department of Pharmacognosy 2022
66 Chitosan Nanoparticles for Meloxicam Ocular Delivery: Development, In Vitro Characterization, and In Vivo Evaluation in a Rabbit Eye Model Department of Pharmaceutics 2022
67 Diterpenoids profile of the marine sponge Chelonaplysilla erecta and candidacy as potential antitumor drugs investigated by molecular docking and pharmacokinetic studies Department of Pharmaceutical Organic Chemistry 2022
68 New pyrimidine/thiazole hybrids endowed with analgesic, anti-inflammatory, and lower cardiotoxic activities: Design, synthesis, and COX-2/sEH dual inhibition Department of Pharmaceutical Organic Chemistry 2022
69 Diverse Glycosides from Gardenia latifolia with Antiviral Activity and Chemosystematic Signifcance Department of Pharmacognosy 2022
70 New 1, 3, 4‐oxadiazoles linked with the 1, 2, 3‐triazole moiety as antiproliferative agents targeting the EGFR tyrosine kinase Department of Pharmaceutical Organic Chemistry 2022